In a world awash with information, Evaluate is here to provide clarity with best-in-class data and expert insight. As we come to the end of a very rocky first half of 2022, where to from here? We share a snapshot of the pharma, biotech and medtech markets to bring you up to speed and help […]
Share:
In a world awash with information, Evaluate is here to provide clarity with best-in-class data and expert insight.
As we come to the end of a very rocky first half of 2022, where to from here? We share a snapshot of the pharma, biotech and medtech markets to bring you up to speed and help guide you forward.
By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.
